Recent Finacing
Recent Raise
MyoKardia develops mutation-specific small-molecule sarcomere modulators for hypertrophic and dilated cardiomyopathies, combining cardiovascular genomics, biophysical/biochemical assays, disease models, medicinal chemistry, and genetic screening.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
